The prooligonucleotide approach. III: Synthesis and bioreversibility of a chimeric phosphorodithioate prooligonucleotide
- 1 February 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (4) , 457-462
- https://doi.org/10.1016/0960-894x(96)00051-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Problems in Interpretation of Data Derived fromin Vitroandin VivoUse of Antisense OligodeoxynucleotidesAntisense Research and Development, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Current concepts in antisense drug designJournal of Medicinal Chemistry, 1993
- Synthesis of Oligonucleotide Analogues with Modified BackbonesSynlett, 1993
- Methylphosphonodiester/phosphodiester chimeric oligodeoxynucleotidesBiochemical Society Transactions, 1992
- Liposome delivery of antisense oligonucleotides: adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotidesJournal of Controlled Release, 1992
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Antisense oligonucleotides: a new therapeutic principleChemical Reviews, 1990
- Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptakeBioconjugate Chemistry, 1990